# 3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension

> **NCT00153049** · PHASE2 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 583 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Telmisartan
- **DRUG:** Hydrochlorothiazide
- **DRUG:** Telmisartan + Hydrochlorothiazide

## Key facts

- **NCT ID:** NCT00153049
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2005-06
- **Final completion:** 2005-06
- **Target enrollment:** 583 (ACTUAL)
- **Last updated:** 2013-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00153049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00153049, "3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00153049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*